Direct and indirect comparison of the efficacy and safety of adalimumab, etanercept, infliximab and golimumab in psoriatic arthritis. (Q38099408)
Jump to navigation
Jump to search
scientific article published on 17 April 2013
Language | Label | Description | Also known as |
---|---|---|---|
English | Direct and indirect comparison of the efficacy and safety of adalimumab, etanercept, infliximab and golimumab in psoriatic arthritis. |
scientific article published on 17 April 2013 |
Statements
Direct and indirect comparison of the efficacy and safety of adalimumab, etanercept, infliximab and golimumab in psoriatic arthritis (English)
R Castaño-Lara
F Puigventós-Latorre
J M Borrero-Rubio
J F López-Vallejo
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference